OpenURL Connection Search

Select item for more details and to access through your institution.

Dihydrocelastrol induces antitumor activity and enhances the sensitivity of bortezomib in resistant multiple myeloma by inhibiting STAT3-dependent PSMB5 regulation.
Published in:
Acta Biochimica et Biophysica Sinica, 2023, v. 55, n. 12, p. 1884, doi. 10.3724/abbs.2023260
By:
- Shuhan Jin;
- Bo Li;
- Bibo Zhang;
- Xuejie Gao;
- Xinyan Jia;
- Li Xu;
- Shuaikang Chang;
- Ke Hu;
- Guanli Wang;
- Zhijian Xu;
- Ting Zhang;
- Dongliang Song;
- Guang Yang;
- Xiaosong Wu;
- Huabin Zhu;
- Cheng Huang;
- Yumeng Lu;
- Jumei Shi;
- Weiliang Zhu;
- Gege Chen
Publication type:
Article
A novel alkaloid compound, DCZ0358, exerts significant antitumor activity in bortezomib-resistant multiple myeloma cells through inhibition of JAK2/STAT3 pathway.
Published in:
Acta Biochimica et Biophysica Sinica, 2023, v. 55, n. 2, p. 215, doi. 10.3724/abbs.2023014
By:
- Bibo Zhang;
- Bo Li;
- Yongsheng Xie;
- Shuaikang Chang;
- Zhijian Xu;
- Huifang Hu;
- Gege Chen;
- Ting Zhang;
- Jun He;
- Xiaosong Wu;
- Huabin Zhu;
- Weiming Lai;
- Dongliang Song;
- Ying Lu;
- Xinyan Jia;
- Weiliang Zhu;
- Jumei Shi
Publication type:
Article
Product of driving pressure and respiratory rate for predicting weaning outcomes.
Published in:
Journal of International Medical Research, 2021, v. 49, n. 5, p. 1, doi. 10.1177/03000605211010045
By:
- Gong, Ju;
- Zhang, Bibo;
- Huang, Xiaowen;
- Li, Bin;
- Huang, Jian
Publication type:
Article
A New Strategy Involving the Use of Peptides and Graphene Oxide for Fluorescence Turn-on Detection of Proteins.
Published in:
Sensors (14248220), 2018, v. 18, n. 2, p. 385, doi. 10.3390/s18020385
By:
- Shi, Huan;
- Zhang, Bibo;
- Liu, Shuwen;
- Tan, Chunyan;
- Tan, Ying;
- Jiang, Yuyang
Publication type:
Article
The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13–MAPK–YWHAE signaling pathway.
Published in:
Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04739-7
By:
- Wang, Yingcong;
- Dong, Sanfeng;
- Hu, Ke;
- Xu, Li;
- Feng, Qilin;
- Li, Bo;
- Wang, Guangli;
- Chen, Gege;
- Zhang, Bibo;
- Jia, Xinyan;
- Xu, Zhijian;
- Gao, Xuejie;
- Zhang, Hui;
- Xie, Yongsheng;
- Lu, Meiling;
- Chang, Shuaikang;
- Song, Dongliang;
- Wu, Xiaosong;
- Jia, Qi;
- Zhu, Huabin
Publication type:
Article
Anti-CD22 Calicheamicin-Inotuzumab Ozogamicin Combined with Venetoclax + Azacitidine in the Treatment of Mixed-Phenotype Acute Leukemia: A Case Report.
Published in:
Turkish Journal of Hematology, 2024, v. 41, n. 3, p. 202, doi. 10.4274/tjh.galenos.2024.2024.0044
By:
- Kongfei Li;
- Yuxiao Wang;
- Renzhi Pei;
- Ying Lu;
- Junjie Cao;
- Xianxu Zhuang;
- Jiaying Lian;
- Bibo Zhang
Publication type:
Article

Found: 6

Dihydrocelastrol induces antitumor activity and enhances the sensitivity of bortezomib in resistant multiple myeloma by inhibiting STAT3-dependent PSMB5 regulation.

A novel alkaloid compound, DCZ0358, exerts significant antitumor activity in bortezomib-resistant multiple myeloma cells through inhibition of JAK2/STAT3 pathway.

Product of driving pressure and respiratory rate for predicting weaning outcomes.

A New Strategy Involving the Use of Peptides and Graphene Oxide for Fluorescence Turn-on Detection of Proteins.

The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13–MAPK–YWHAE signaling pathway.

Anti-CD22 Calicheamicin-Inotuzumab Ozogamicin Combined with Venetoclax + Azacitidine in the Treatment of Mixed-Phenotype Acute Leukemia: A Case Report.